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A central role for vimentin in regulating repair 
function during healing of the lens epithelium
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George Washington University, Washington, DC 20037
ABSTRACT Mock cataract surgery provides a unique ex vivo model for studying wound re-
pair in a clinically relevant setting. Here wound healing involves a classical collective migration 
of the lens epithelium, directed at the leading edge by an innate mesenchymal subpopulation 
of vimentin-rich repair cells. We report that vimentin is essential to the function of repair cells 
as the directors of the wound-healing process. Vimentin and not actin filaments are the pre-
dominant cytoskeletal elements in the lamellipodial extensions of the repair cells at the 
wound edge. These vimentin filaments link to paxillin-containing focal adhesions at the lamel-
lipodial tips. Microtubules are involved in the extension of vimentin filaments in repair cells, 
the elaboration of vimentin-rich protrusions, and wound closure. The requirement for vimen-
tin in repair cell function is revealed by both small interfering RNA vimentin knockdown and 
exposure to the vimentin-targeted drug withaferin A. Perturbation of vimentin impairs repair 
cell function and wound closure. Coimmunoprecipitation analysis reveals for the first time 
that myosin IIB is associated with vimentin, linking vimentin function in cell migration to myo-
sin II motor proteins. These studies reveal a critical role for vimentin in repair cell function in 
regulating the collective movement of the epithelium in response to wounding.
INTRODUCTION
In response to injury, a repair process essential to the homeostasis 
and survival of an organism is quickly initiated to regenerate the 
damaged tissue. After wounding of an epithelial tissue, reepithelial-
ization involves “collective migration” of the epithelial cells into the 
wounded area, a process that is regulated by “leader” cells at the 
wound edge (Friedl and Gilmour, 2009; Khalil and Friedl, 2010; 
Weijer, 2009; Walker et al., 2010). These leader cells have a mesen-
chymal-like phenotype, including front-to-back polarity (Revenu and 
Gilmour, 2009) and the extension of polarized membrane protru-
sions (filopodia, lamellipodia) in the direction of wound closure 
(Omelchenko et al., 2003; Pastor-Pareja et al., 2004; Poujade et al., 
2007). Despite their highly migratory phenotype, leader cells remain 
integrally linked to the collectively migrating epithelium that follows 
them. Although leader cells are important to movement of the epi-
thelial sheet to close the wound, the mechanisms by which they 
regulate this process are unclear.
Leader cells can emerge in tissue or culture conditions from a 
partial mesenchymal transition of the endogenous epithelium (EMT) 
or alternatively from cells with a mesodermal lineage, such as fibro-
blasts or fibrocytes. Such cells are believed to direct the collective 
cell migration/invasion of epithelial cancer cells (Gaggioli et al., 
2007; Kitamura et al., 2007; Montell, 2008; Weijer, 2009; Khalil and 
Friedl, 2010), enabling the epithelial cells following behind them to 
retain their intrinsic characteristics as they are directed to move to a 
new site. In a mock cataract surgery wound-healing model, which 
provides the opportunity to examine the injury repair process in re-
sponse to a clinically relevant wounding, the leader cells that direct 
epithelial wound healing are derived from a mesenchymal repair cell 
progenitor subpopulation innate to the epithelium (Walker et al., 
2007, 2010). In response to injury, the repair cell progenitors are 
activated, expand in number, assume a migratory morphology, and 
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epithelial cells migrated across the denuded area of the basement 
membrane to repair the wound area (Figure 1B, D1–D3).
For ease of reference, the region of the capsule to which the lens 
epithelium is originally attached was named the original attachment 
zone (OAZ; Figure 1, A, B, and E). It is located on the projections of 
the star-shaped explant. The circular cell-free area of the basement 
membrane in the middle of the explant from where the lens fiber 
cells were removed, and onto which the injured lens epithelial cells 
must migrate to heal the wound, will be called the cell migration 
zone (CMZ; Figure 1, A, B, D, and E). As occurs after cataract surgery 
in vivo and is characteristic of the wound-healing processes of epi-
thelia, the injured lens epithelial cells emerged from the OAZ and 
migrated collectively across the CMZ (Figure 1, B and D, modeled in 
E), paralleling the mechanism known as collective migration. The 
repair cell progenitors, which in the uninjured lens are located in 
small niches among the cells of the lens epithelium, give rise to a 
population of mesenchymal repair cells that migrate to the wound 
edge immediately upon injury and function as the leader cells in the 
repair process (Walker et al., 2010). At the leading edge of the CMZ 
the repair cells (Figure 1, D, and modeled in red, E) extended cel-
lular protrusions along the lens basement membrane capsule in the 
direction of movement.
The collective movement of the epithelium onto the denuded 
lens capsule in response to wounding began rapidly, detectable 
within a few hours of injury. Wound closure was extensive by 1 d 
postinjury, the open wound area measuring on average 
996,000 μm2, representing 67% closure of the wound (Figure 1, B 
and C). The repair process was completed within 3 d. The classical 
properties of this ex vivo wound repair model and its similarity to 
the wound repair process in vivo provided a unique opportunity to 
investigate the molecular mechanisms that govern repair cell func-
tion in response to injury of an epithelium.
Vimentin intermediate filaments are the dominant 
cytoskeletal elements of repair cells at the wound edge
To elucidate the functional properties of repair cells responsible 
both for their highly motile phenotype and their role in directing the 
response of an epithelium to wounding, we investigated the subcel-
lular organization of their cytoskeleton after lens injury. These stud-
ies included examination of the organization and distribution of mi-
crofilaments, microtubules, and vimentin intermediate filaments, 
cytoskeletal elements whose coordinate action have been impli-
cated in cell migration and wound repair. After mock cataract sur-
gery the injured lens explants were fixed at 1 d postinjury, labeled 
for vimentin, and double stained for F actin (Figure 2, A–C) or α-
tubulin, a principal component of microtubules (Figure 2, D–F). The 
cells at the leading edge were imaged by confocal microscopy. 
Although actin filaments are the cytoskeletal element typically impli-
cated in cell motility, surprisingly few actin filaments could be de-
tected in the lamellipodial processes extended by the repair cells 
(Figure 2, B and C, arrow). In contrast, there was a relatively high 
concentration of actin filaments comprising the cytoskeleton of the 
collectively moving epithelial cells located just behind the repair 
cells at the wound edge (Figures 2, B and C). Unique to the highly 
motile repair cell population was their rich concentration of vimentin 
intermediate filaments, which extended throughout these cells and 
their lamellipodial extensions through to the lamellipodia tips 
(Figure 2, A, C, D, and F). Just behind the leading edge, more-sta-
ble vimentin intermediate filaments were predominant (Figure 2A, 
arrow), whereas near the tips of the extended lamellipodia, nonfila-
mentous vimentin particles and squiggles (short intermediate fila-
ments) were also present (Figure 2A, arrowhead). Vimentin particles 
move over the epithelial cells’ apical surfaces to reach the wound 
edge (Walker et al., 2010). Here repair cells have a requisite function 
in regulating wound closure (Walker et al., 2010).
A defining feature of repair cells in most wound-repair models, 
including mock cataract surgery, is their high expression of vimentin 
intermediate filaments (Walker et al., 2010). Vimentin is considered 
a hallmark of the mesenchymal phenotype, expressed by cells in-
volved in migration (Mendez et al., 2010), wound healing (SundarRaj 
et al., 1992; Buisson et al., 1996), and metastasis (Hendrix et al., 
1996). Migration is impaired in vimentin-deficient fibroblasts (Eckes 
et al., 1998), and wound healing is delayed in vimentin-null mice 
(Eckes et al., 2000). Despite the connection between vimentin-rich 
cells and both cell migration and wound repair (Eckes et al., 1998, 
2000; Gilles et al., 1999; Rogel et al., 2011), much remains to be 
learned about the mechanisms by which vimentin regulates leader 
cell function in the wound repair process. Here we investigate the 
role of vimentin in repair cells during wound healing.
In studies with a mock cataract surgery model we discovered that 
vimentin was intrinsic to the migratory function of repair cells and to 
their role in ensuring normal wound closure. At the leading edge of 
the wound, the repair cells extend vimentin-rich, actin-poor lamelli-
podial processes. The vimentin filaments are linked to paxillin-rich 
focal adhesion contacts at the cells’ lamellipodial tips, a region also 
rich in the motor protein myosin IIB. Biochemical analysis provides 
the first evidence that the motor protein myosin IIB is complexed to 
vimentin filaments. Disrupting vimentin function by small interfering 
RNA (siRNA) knockdown or with withaferin A (WFA), a drug that in-
terferes with vimentin function, blocks the ability of repair cells at the 
wound edge to extend lamellipodial processes and slows wound 
closure. These studies position vimentin as a crucial cytoskeletal me-
diator of repair cell function in the wound-healing process of lens 
epithelial cells in response to mock cataract surgery.
RESULTS
Leader/follower paradigm of epithelial wound healing 
in an ex vivo mock cataract surgery injury model
Ex vivo mock cataract surgery epithelial explants have distinct ad-
vantages over other culture models for investigating the regulatory 
mechanisms of wound repair (Walker et al., 2010). One of the most 
significant is the ability to examine and manipulate the natural 
wound-healing process within a cell’s native microenvironment. Also 
central to the value of this particular wound model are the intrinsic 
properties of the lens itself—it is a self-contained organ surrounded 
by a thick basement membrane (the lens capsule), avascular, not 
innervated, with no associated stromal compartment. Because the 
lens is removed from the embryo before performing the mock cata-
ract surgery, the cells involved in regulating the repair process are 
limited to those innate to the lens. The wounding associated with 
cataract surgery results from extraction of the differentiated lens fi-
ber cells through a small opening in the anterior lens capsule 
(Figure 1A; Walker et al., 2010). This procedure leaves behind both 
the lens epithelium, which borders the fiber cells in the intact lens, 
and a subpopulation of mesenchymal repair cell progenitors whose 
progeny are essential for effective wound healing of the lens epithe-
lium (Walker et al., 2010). For unobstructed imaging of the response 
of both the lens epithelium and its associated repair cells to injury, 
the wounded lens was flattened on a tissue culture substrate cell 
side up, forming a star-shaped explant (Figure 1B; T0). The epithe-
lial cells surrounded a highly reproducible circular wound area of 
∼3 × 106 μm2 (Figure 1, B and C; T0). The wound edge (leading 
edge) was the site where the extracted lens fiber cells had met the 
lens epithelium. In response to this mock cataract surgery, the 
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Microtubule function is required for extension of vimentin-
rich lamellipodia by repair cells
Because the distribution of intermediate filaments in the cell is de-
pendent on the microtubule network, the depolymerization of mi-
crotubules has been used as an approach to collapse intermediate 
filaments (Geuens et al., 1983; Forry-Schaudies et al., 1986). Expo-
sure of injured lens epithelial explants to the microtubule depo-
lymerization agent nocodazole from the time of wounding through-
out the first day in culture effectively depolymerized microtubules 
and collapsed the vimentin cytoskeleton and the vimentin-rich 
lamellipodial protrusions normally extended by repair cells at wound 
edge (Figure 2, H and J). The dual effect of nocodazole on microtu-
bules and vimentin intermediate filaments dramatically impaired 
wound closure (Figure 2, K and L), implicating both of these cy-
toskeletal elements in the wound repair process in the mock cata-
ract surgery wound repair model.
and squiggles are more-soluble forms of vimentin that can serve as 
precursors to mature polymerized vimentin filaments (Prahlad et al., 
1998; Herrmann and Aebi, 2000) and also can have separate func-
tions where they may participate in regulating the migratory func-
tion of repair cells during wound healing. The vimentin- rich protru-
sions extended at the leading edge by the repair cells were verified 
as lamellipodia by the high-level expression of the lamellipodial 
marker cortactin (Supplemental Figure S2). Microtubules were also 
present in the lamellipodia of these cells, often coincident with 
the vimentin filaments, but were most highly concentrated in the 
rearward aspects of the repair cells (Figure 2, D–F). These results 
showed that vimentin filaments were the principal cytoskeletal 
element of the repair cells at the leading edge and suggested that 
there was a principal role for vimentin filaments in directing move-
ment of the mesenchymal repair cells during wound healing of the 
lens epithelium.
FIguRE 1: The lens ex vivo wound repair model. (A) Mock cataract surgery was performed on E15 chick embryo lenses 
ex vivo, and cuts were made in the anterior lens capsule to flatten the wounded lens epithelium (green) on a culture 
dish. (B) The wounded epithelium remained attached to its endogenous basement membrane—the lens capsule—in the 
OAZ, just adjacent to the wound area, the region of the basement membrane (BM) from which the lens fiber cells were 
removed and onto which the lens epithelial cells migrate to fill the wound area, which becomes the CMZ. The dashed 
white line represents the border of the OAZ and CMZ. Here, a single wounded lens explant is imaged from the time of 
injury (T0) through day 3 in culture. Bar, 500 μm. (C) Quantification of wound closure, completed within 3 d in culture 
over an average of six experiments. (D) High-magnification image of cells at the leading edge in the CMZ, similar to the 
region boxed in B. Arrows identify the repair cells at the leading edge and the follower cells of the lens epithelium, 
modeled on the right. Bar, 1 00 μm. (E) Model depicting the OAZ and the CMZ, which is composed of cells located at 
the leading edge and lens epithelial follower cells.
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punctate in appearance. Vimentin filaments were enriched in lamel-
lipodial extensions also rich in α6 integrin (Figure 3K), a region with 
few F-actin filaments (Figure 3M). The punctate staining observed 
for both α6 and β4 integrins in these cells (Figure 3, I and L) could 
reflect both more discrete types of adhesion structures and integrin 
trafficking. Integrin recycling that is associated with directed cell mi-
gration has been shown to involve vimentin function (Ivaska et al., 
2005; Fortin et al., 2010). These data suggested that vimentin fila-
ment function in the repair cells was linked to its interaction with 
α6β4 integrin in the cells’ lamellipodial extensions.
Vimentin solubility increased in migratory cells during lens 
wound healing
Intermediate filaments were first described for their function as sta-
ble, rope-like structures that provide resistance to mechanical stress 
(Lazarides, 1980; Kim and Coulombe, 2007). It is now understood 
that intermediate filaments are in fact dynamic structures (Prahlad 
et al., 1998; Helfand et al., 2004; Eriksson et al., 2009) and that vi-
mentin can exist in different states of assembly and subcellular orga-
nization (Kim and Coulombe, 2007; Goldman et al., 2008, 2012). 
Precursors to mature polymerized vimentin filaments include deter-
gent-soluble nonfilamentous vimentin particles and short intermedi-
ate filament structures (squiggles) that can form functional pools 
with distinct cellular roles (Ivaska et al., 2007; Kim and Coulombe, 
2007; Goldman et al., 2012). For instance, in response to nerve cell 
injury, soluble vimentin mediates the long-distance retrograde trans-
port of phosphorylated Erk from the axon to the cell body (Perlson 
et al., 2005). Here we examined whether there were dynamic 
changes in the state of vimentin organization associated with cell 
migration in response to injury by examining whether there were 
increases in vimentin solubility. To accomplish this analysis, we ex-
amined the state of vimentin solubility/insolubility at the time of in-
jury (T0) and compared it with that in both the OAZ and the region 
of active migration (CMZ) at day 1 (D1) postinjury (modeled in 
Figure 1D). Vimentin solubility was determined by its detergent ex-
tractability. Tissue samples were extracted sequentially with 1) Triton 
X-100, a mild, nonionic detergent, to isolate the most soluble forms 
of vimentin, 2) Triton X-100/octylglucoside (TX/OG) to isolate mem-
brane proteins, including integrin receptors, in lipid rafts (Brown and 
Rose, 1992) and their associated cytoskeleton, and 3) a 4% SDS-
containing buffer that solubilizes the highly detergent-insoluble (HI) 
cytoskeletal fraction, including the classical, highly stable intermedi-
ate filament population (Leonard et al., 2011). At the time of injury 
(T0) the majority of the vimentin filaments (60%) were present in a 
highly detergent-insoluble (HI) form; the remainder was divided be-
tween the highly soluble and lipid raft–linked fractions (Figure 4A). 
Vimentin solubility changed dramatically in the zone of cell migra-
tion in response to injury, with only ∼33% of vimentin remaining 
highly insoluble and the majority of vimentin (67%) moving to the 
soluble, detergent-extractable fractions (Figure 4C, 45% TX soluble, 
22% TX/OG soluble). Of interest, the most significant increase in 
solubility was in the lipid raft fraction. Lipid raft–associated vimentin 
is known to function as a scaffold on which to recruit and localize 
signaling complexes (Runembert et al., 2002; Sprenger et al., 2006; 
Meckes et al., 2013). Therefore, the increase in the lipid raft–associ-
ated vimentin in the CMZ suggested a specific function for vimentin 
at these specialized microdomains in signaling required for cell mi-
gration. The results of these studies involving changes in solubility 
of vimentin in response to wounding demonstrated that dynamic 
changes in vimentin intermediate filament organization are involved 
in regulating the function of this cytoskeletal element in cell migra-
tion in response to wounding.
Vimentin filaments of repair cells are linked to paxillin-rich 
focal adhesions
The discovery of vimentin-rich intermediate filaments as the primary 
cytoskeletal element in the lamellipodial processes of repair cells 
suggested that in these cells, intermediate filaments might be a pri-
mary link between adhesion plaques of these motile cells and the 
cytoskeleton. For these studies, paxillin was used to label these clas-
sical adhesion structures, as it is an integral component of integrin 
focal adhesion plaques (Figure 3, A and D, arrows). Wounded lens 
explant cultures were fixed at day 2 postinjury, immunolabeled for 
paxillin, costained for F-actin (Figure 3B) or vimentin (Figure 3E), and 
imaged by confocal microscopy. Prominent paxillin-rich focal adhe-
sions were localized at the tips of the lamellipodial protrusions of the 
repair cells at the leading edge of the wound (Figure 3, A, C, D, and 
F, arrows). As shown earlier, little filamentous actin was extended 
into the lamellipodia or linked to paxillin focal adhesion plaques 
(Figure 3, B and C). Instead, significant colocalization was found be-
tween vimentin filaments and these focal adhesions, with vimentin 
intermediate filaments extending to and appearing to insert into 
the site of these focal adhesion structures (Figure 3, E and F, arrow 
and inset), revealing that vimentin intermediate filaments are the 
predominant cytoskeletal link to the paxillin-rich integrin adhesion 
plaques of repair cells.
To further examine the association between paxillin and vimentin 
in the wound-repair cultures, we performed coimmunoprecipitation 
analysis (immunoprecipitate [IP], paxillin; blot, vimentin; Figure 3G). 
For this study, the CMZ and the OAZ were separated by microdis-
section to examine these regions separately by biochemical analy-
sis, providing a powerful approach for studying migration-specific 
molecular interactions. OAZ and CMZ regions of the ex vivo 
wounded explants were analyzed at days 1, 2, and, 3 in culture. Vi-
mentin was discovered linked to paxillin predominately in the CMZ, 
the zone of migration (Figure 3, G and H), most highly at day 2 
postinjury, the same time point at which paxillin adhesion plaques 
were so prominently observed by immunolocalization analysis 
(Figure 3, A and D). The association between vimentin and paxillin 
was significantly diminished by day 3 postinjury, consistent with a 
time when wound closure typically was completed and leader cell 
function no longer required (Figure 3H). These results confirm the 
role of vimentin intermediate filaments as the cytoskeletal elements 
linked to paxillin focal adhesion plaques during the period of great-
est cell migration to repair the wound.
Integrin α6β4 enriched in lamellipodial tips of repair cells 
at the wound edge
Integrin α6β4 is distinct among most integrin cell-matrix adhesion 
receptors for its ability to link to intermediate filaments (Gomez 
et al., 1992; Rezniczek et al., 1998). Initially discovered as the integ-
rin receptor of hemidesmosomes (Carter et al., 1990; Stepp et al., 
1990), α6β4 integrin has since also been assigned a role in cell mo-
tility, first identified in cells associated with disease states such as 
cancer (Rabinovitz et al., 1995). We performed immunolocalization 
analysis for both α6 and β4 integrin subunits in the lens wound re-
pair cultures at 1 d postinjury to investigate whether α6β4 could 
function as the cell-surface receptor linked to vimentin intermediate 
filaments in the repair cells at the leading edge of the wounded lens 
epithelium. Wounded mock cataract surgery cultures were immu-
nostained for α6 or β4 integrin and costained for vimentin or cola-
beled with F-actin. The results show that the vimentin-rich repair 
cells were high expressers of both α6 and β4 integrins (Figure 3, 
I–N, arrows), which highly localized to the lamellipodial protrusions 
of repair cells at the leading edge of the wound and were often 
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FIguRE 2: Extension of vimentin-rich lamellipodia at the wound edge depends on microtubule function. At 1 d 
postinjury, wounded lens explants were immunofluorescence labeled for vimentin (A, D, red) and α-tubulin (E, green) or 
colabeled for F-actin using fluorescent phalloidin (B, green), overlaid in C and F. Confocal imaging focused at the wound 
edge revealed that the protruding processes of the repair cells had few actin filaments but were rich in vimentin 
intermediate filaments. Filamentous vimentin (arrow) was concentrated toward the rear aspects of the repair cells, 
whereas nonfilamentous vimentin particles and squiggles (arrowhead) were observed near the lamellipodia tips (A–C). 
α-Tubulin (E, green) was detected within lamellipodia coincident with vimentin but was more concentrated at the back 
end of the cells. Exposure of wounded lens explants to the microtubule depolymerization drug nocodazole (3 μM) 
caused disassembly of microtubules of the repair cells at the wound edge (H, red, compare to control, G, red). Vimentin 
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microscopy. Z-stacks were collected and the results displayed both 
as a single optical x-y plane (Figure 6B, bottom) and in an orthogo-
nal view (Figure 6B, top). Treatment with 1.5 μM WFA had only mini-
mal effect on the repair cells, whereas a dose of 2.5 μM WFA and 
higher caused significant cell rounding, and the repair cells accumu-
lated and piled up near the wound edge. At the two higher concen-
trations of WFA (2.5 and 3.5 μM), as with the vimentin siRNA knock-
down studies, the repair cells failed to move onto and extend lamel-
lipodia along the wounded area of the lens basement membrane 
capsule (Figure 6B). This phenomenon was seen best in the orthog-
onal view (Figure 6B).
Because vimentin intermediate filaments can interact with other 
cytoskeletal filaments, including microtubules and microfilaments 
(Chang and Goldman, 2004), it is not surprising that exposure of 
some cell types to WFA has been reported to change the organiza-
tion of F-actin and/or microtubules, together with its effects on their 
vimentin filaments (Bargagna-Mohan et al., 2007; Grin et al., 2012). 
Therefore, for our studies, it was important to determine whether 
the effects of WFA on the vimentin filaments of cells in the wounded 
explant cultures also affected the organization of other cytoskeletal 
filaments. We found that there was little effect on the organization 
of either F-actin or microtubules (stained for α-tubulin) when the 
wounded cultures were exposed to WFA (Figure 6, C and D). Par-
ticularly striking was the ability of the cortical actin filaments of the 
lens epithelial cells to maintain both their integrity and their distribu-
tion in the presence of WFA (Figure 6C, arrow). Similarly, the integ-
rity of actin filaments (Figure 6C, arrowhead) and microtubules 
(Figure 6D) was maintained in the repair cells at the wound edge 
despite the dramatic change in their cell shape that accompanied 
collapse of their vimentin intermediate filaments. These results 
support the conclusion that in the ex vivo wound repair cultures that 
we study here, WFA functioned as a vimentin-specific cytoskeletal 
inhibitor.
The effect of WFA on vimentin had a significant effect on wound 
closure, suppressing the collective migration of the lens epithelium 
across the wounded area of the lens capsule (Figure 6E). The effects 
of WFA on wound closure were very similar to those obtained after 
vimentin siRNA knockdown. The effect of WFA on wound repair was 
dose dependent (Figure 6F). The lowest concentration tested, 
1.5 μM WFA, which had a minimal effect on repair cell morphology 
(Figure 6B), did not impair wound closure (Figure 6F). Higher con-
centrations of WFA that both collapsed the intermediate filament 
network and rounded the repair cells (Figure 6B) slowed wound clo-
sure, with the greatest effect at the highest concentration tested 
(Figure 6, E and F). Given that WFA has been reported to induce 
apoptosis in certain cell types (Bargagna-Mohan et al., 2007; Lahat 
et al., 2010; Grin et al., 2012), we examined whether the effects of 
this drug on wound closure were related to an induction of cell 
death in the repair cells. Few apoptotic cells were detected by ter-
minal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) 
assay in the region of wound repair in WFA-treated, wounded ex-
plant cultures, similar to untreated controls (Supplemental Figure S3). 
Therefore the suppression of wound closure in the presence of 
Knockdown of vimentin prevents formation of lamellipodial 
protrusions at the wound edge and suppresses wound 
closure
High-level expression of the vimentin intermediate filament protein 
is a prominent feature of the repair cell population that modulates 
wound closure in the mock cataract surgery wound repair model 
(Walker et al., 2010). This prominence of vimentin is a feature of the 
repair cells both before injury, when they are present in niches as 
precursor cells, and after their activation in response to wounding 
(Walker et al., 2010). These repair cells migrate quickly to the wound 
edge (Walker et al., 2010), where the studies presented here show 
that they extend vimentin-rich, F-actin–poor lamellipodia along the 
basement membrane capsule exposed by the injury (Figure 2, A–C). 
These results suggested that as a defining feature of repair cells at 
the wound edge, vimentin could be required for extension of these 
lamellipodial processes and, more important, the function of these 
vimentin-rich repair cells in wound closure. To investigate the pos-
sibility of a functional role for the vimentin intermediate filament 
protein in the repair process, we used a vimentin siRNA knockdown 
approach. For this study we knocked down vimentin expression at 
the time of wounding in the mock cataract surgery ex vivo wound 
repair culture model. This siRNA approach effectively suppressed 
vimentin expression (Figure 5A), and as a result the cells at the lead-
ing edge of the wound were prevented from extending lamellipo-
dial protrusions (Figure 5B), and wound closure was suppressed 
(Figure 5, C and D). These results provide strong evidence that 
vimentin is essential for lamellipodial protrusion formation by the 
vimentin-rich cells at the wound edge and for closure of a wound 
created by mock cataract surgery in our wound repair model.
Inhibition of vimentin with WFA impairs repair function 
and slows wound repair
Type III intermediate filament proteins such as vimentin have been 
identified as potent in vivo druggable targets for WFA, a steroidal 
lactone, as in the case of tumor suppression (Lahat et al., 2010), 
corneal fibrosis, and glaucoma (Bargagna-Mohan et al., 2012, 2013). 
WFA can covalently bind to vimentin, causing aggregation of inter-
mediate filaments, altering filament distribution and disrupting fila-
ment function (Bargagna-Mohan et al., 2007). Of interest, soluble 
forms of vimentin are highly sensitive to WFA (Bargagna-Mohan 
et al., 2013). We exposed newly wounded mock cataract surgery 
cultures to WFA as an alternative mechanism to investigate the role 
of vimentin in this wound repair model. Immunofluorescence analy-
sis at 1 d postinjury verified that WFA had a significant effect on the 
organization of the vimentin intermediate filaments in repair cells 
and on repair cell morphology. In the presence of WFA the vimentin 
filaments aggregated and clustered around the nucleus. In response 
to collapse of the vimentin filament network and subsequent loss of 
tensegrity, repair cells became highly rounded and failed to main-
tain their mesenchymal shape (Figure 6A). The dose-dependent ef-
fect of WFA on repair cell localization was determined after 24-h 
exposure to the drug beginning at the time of injury. The cells were 
labeled for both vimentin and F-actin and imaged by confocal 
filaments, which normally extend throughout the repair cells (control, I, green), were collapsed and aggregated when 
the microtubule network was depolymerized (nocodazole, J, green). Coincident with the loss of microtubules and 
vimentin-rich lamellipodia extensions, exposure to nocodazole had a significant inhibitory effect on wound closure, 
shown in phase contrast (K) and quantified as an average of three experiments (L). Bar, 20 μm (A–J), 500 μm (K). Images 
presented as confocal projected images. Arrows identify repair cell at the wound edge (A–F). Secondary antibody 
controls were performed, which demonstrated specificity of antibody staining (Supplemental Figure S1).
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our data indicated that vimentin intermediate filaments played a 
central role in regulating repair cell function in response to injury, we 
investigated whether there might be a coordinate role for myosin II 
with vimentin. For these studies we examined both myosin IIA and 
IIB isoforms, as each has distinct motor activities, subcellular loca-
tions, and functions in migrating cells (Even-Ram and Yamada, 2007; 
Vicente-Manzanares et al., 2009; Wang et al., 2011). The distribu-
tion of myosin IIA and IIB in repair cells was examined by coimmu-
nostaining wounded cultures for these two myosin II isoforms. These 
studies showed a prominence of myosin IIB over myosin IIA in the 
repair cells at the wound edge (Figure 7, A–C). These two isoforms 
had distinct patterns of distribution. In contrast to myosin IIB, myo-
sin IIA was highly localized along stress fibers, reflecting its known 
function with F-actin (Figure 7B, arrows).
To investigate the possibility of vimentin-linked myosin II func-
tion, we performed coimmunoprecipitation analysis (IP, vimentin; 
blot, myosin II [A or B]) at 1 d after injury, a time of active cell migra-
tion. The results revealed a previously unknown linkage of myosin II 
with vimentin (Figure 7D) and showed that this phenomenon 
predominantly reflected the association of vimentin with the myosin 
WFA was most likely due to the altered behavior of repair cells when 
they fail to extend along the wound edge. Because the soluble pool 
of vimentin is highly sensitive to WFA, these results could reflect a 
particular role for this dynamic vimentin population that our studies 
showed is enhanced in the cell population migrating to fill the 
wound area. Because before the identification of WFA as a vimentin 
inhibitor acrylamide was used as a classical approach to disrupt vi-
mentin function (Durham et al., 1983; Eckert, 1985; Sager, 1989), 
wounded lens explants also were exposed to acrylamide for 24 h 
from the time of injury. Acrylamide was found to inhibit wound heal-
ing in a dose-dependent manner (Supplemental Figure S4). To-
gether the vimentin siRNA knockdown and WFA results show, for 
the first time, the importance of vimentin to repair of cell function in 
the regulation of wound closure of an injured epithelium.
Myosin II is linked to vimentin in repair cells
Nonmuscle myosin II motor proteins are viewed as master regula-
tors of migration, implicated in protrusion extension, adhesion dy-
namics, and polarization of migrating cells (Vicente-Manzanares 
et al., 2009), typically in conjunction with actin filaments. Because 
FIguRE 3: The relationship between α6β4, paxillin, and vimentin in the protrusive processes extended by repair cells at 
the wound edge. Vimentin (E, green) colocalized and extended to and inserted into prominent paxillin-rich adhesion 
plaques (A, D, red) at the tips of these protrusive processes, which contained little actin (B, green) filaments. (C) Overlay 
of paxillin and actin. (F) Overlay of paxillin and vimentin. Arrows identify paxillin-rich focal adhesions preferentially linked 
to vimentin. Inset, vimentin and paxillin colocalization at higher magnification (D–F). (G) Coimmunoprecipitation analysis 
of wounded explants at D1–D3 in culture examined in wounded explants after separation into OAZ and CMZ fractions. 
Samples were immunoprecipitated for paxillin and the immunoprecipitates immunoblotted for vimentin and paxillin. 
Blots included whole-cell lysates (WCLs) blotted for total vimentin and paxillin expression in each fraction. Results were 
quantified over three independent experiments and are represented as the ratio of vimentin to paxillin in each fraction 
(H). Results demonstrate that vimentin interacts with paxillin predominately in the CMZ, with the greatest interaction 
occurring at D2, a time of significant motility for wound closure (H). Cells were labeled for α6 integrin (I, red) or β4 
integrin (L, red) and colabeled with vimentin (J, green) or F-actin (M, green), respectively, with overlays in K and N, at 1 d 
after injury. Both α6 integrin and β4 integrin were concentrated in the protrusive processes of the repair cells, into which 
vimentin intermediate filaments but few F-actin filaments were extended (arrows). All images are confocal projected 
images except insets of paxillin, vimentin, and overlay (D–F, insets) and α6 integrin, vimentin, and overlay (I–K). 
(A–F, and I–N) were taken at the leading edge of the CMZ. Bar, 20 μm, for inset, 5 μm. Secondary antibody controls 
were performed, which demonstrated specificity of antibody staining (Supplemental Figure S1).
FIguRE 4: Vimentin solubility increased within the CMZ in response to injury. Ex vivo wounded explants were collected 
immediately after injury (time 0) and at 1 d postinjury (D1) after separating by microdissection into OAZ and CMZ 
domains (A–C). Samples were then sequentially extracted in Triton X-100, which solubilizes cytoplasmic and membrane-
associated proteins, and TX/OG, which isolates membrane-associated proteins and lipid rafts, and TX/OG-resistant 
pools of vimentin were solubilized in SDS (4%). The SDS fraction is referred to as the highly insoluble population (HI). In 
contrast to the SDS, both the Triton and TX/OG fractions represent soluble pools of vimentin. The amount of soluble 
vimentin increased from T0 to D1 postinjury within the cell population, migrating across the CMZ (C). At T0, 60% of 
vimentin filaments were present in the HI fraction, whereas only ∼33% of vimentin remained HI in the CMZ (A, C). Within 
the CMZ the majority of vimentin remained soluble (45% TX soluble and 22% TX/OG soluble) (C). The percentage total 
amount of vimentin in each fraction was quantified over five independent experiments.
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cataract surgery (Walker et al., 2010). The 
repair cells, rich in vimentin, quickly traveled 
to the wound edge to modulate the repair 
process (Walker et al., 2010). The present 
study adds these repair cells to the list of 
cells that can function as leader cells at the 
wound edge in response to injury. We also 
show that vimentin is essential to repair cell 
function, including the ability to adopt and 
maintain a mesenchymal morphology at the 
wound edge, extend lamellipodia along the 
basement membrane, and modulate the re-
pair process. A high concentration of vi-
mentin filaments stretched out to the tips of 
the lamellipodia of the repair cells, similar to 
the findings of Helfand et al. (2011), and 
nonfilamentous vimentin particles were en-
riched in these lamellipodia regions. Non-
filamentous vimentin is a soluble form of 
this intermediate filament protein, which 
has particular importance to our study, as 
soluble intermediate filament proteins are 
associated with dynamic cell processes such 
as wound closure and invasion (Windoffer 
et al., 2011). An unusual property of the 
lamellipodia of the repair cell population is 
the finding that vimentin filaments also ex-
tended to the tips of lamellipodia, where 
they were linked to paxillin in focal adhesion 
plaques. The fact that surprisingly few actin 
filaments were present in these lamellipo-
dial extensions likely provides the need 
for vimentin filament association with adhe-
sion complexes, in contrast to more-classi-
cal models of actin-based lamellipodial 
movement. Extension of vimentin through-
out the repair cells required microtubule 
function. The role of actin filaments and mi-
crotubules in focal adhesion dynamics is 
well studied, but much less is understood 
about the role of intermediate filaments at 
these adhesion complexes. Vimentin inter-
mediate filament–linked focal adhesions 
have been detected in cell types such as fi-
broblasts (Bershadsky et al., 1987) and en-
dothelial cells (Gonzales et al., 2001; Kreis 
et al., 2005; Bhattacharya et al., 2009).
Vimentin can regulate both the structure 
and function of focal adhesions (Eckes et al., 
1998; Tsuruta and Jones, 2003). For in-
stance, vimentin regulates the size of focal adhesions and stabiliza-
tion of cell-matrix adhesion strength in endothelial cells under shear 
stress (Tsuruta and Jones, 2003). The formation of intermediate fila-
ment–linked focal adhesions may be specific to cell type or adapted 
under conditions in which cells are subjected to stress and/or me-
chanical forces. Studies show that intermediate filaments can be 
recruited to focal adhesions in a process dependent on micro-
tubules (Bhattacharya et al., 2009) and that vimentin filaments can 
be delivered along microtubules to focal adhesions, where they are 
assembled (Helfand et al., 2002; Bhattacharya et al., 2009). These 
studies are consistent with our finding that vimentin functions at the 
leading edge in lamellipodia, including in the establishment of 
IIB isoform (Figure 7, D and E). Further evidence of a vimentin-linked 
myosin IIB role was the finding that myosin IIB and vimentin were 
highly colocalized in the repair cell population at the wound edge 
(Figure 7H, arrows and inset). The findings reveal a previously unap-
preciated association of myosin II motor proteins with vimentin in 
repair cells responding to injury, suggesting a role for myosin II mo-
tor activity in vimentin function during wound healing.
DISCUSSION
Our previous studies revealed the existence of a subpopulation of 
repair cell progenitors, innate to the lens epithelium, that were acti-
vated in response to the injury inflicted by performing a mock 
FIguRE 5: Knockdown of vimentin prevented lamellipodial extension at the wound edge and 
slowed wound closure. A siRNA approach was used to knock down vimentin expression (SiVim) 
in the ex vivo wounded explants to determine the effects on extension of lamellipodial 
processes at the wound edge and wound closure. Control cultures were transfected with 
siControl nontargeting siRNAs (SiC). (A) Immunoblot analyses show a reduction in vimentin 
expression. Results were quantified over four independent wounded ex vivo explants for each 
treatment and are represented as a ratio of vimentin to GAPDH. (B, high magnification) 
Protrusion formation at the leading edge is significantly inhibited in SiVim compared with 
SiC-treated ex vivo wounded explants, shown in phase contrast imaging. (C) Wound closure for 
SiC-treated and SiVim-transfected ex vivo wounded explants, in phase contrast imaging. 
Transfection of SiVim significantly inhibited wound closure compared with SiC-transfected ex 
vivo wounded explants. (D) Wound closure quantified for six independent wounded ex vivo 
explants for each treatment.. Bar, 500 μm (phase images), except for high magnification in B, 
250 μm.
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for soluble vimentin in disease processes. Expression of vimentin 
is often correlated with the metastatic state (Hendrix et al., 1996). 
Nonfilamentous vimentin particles and squiggles, considered 
soluble forms of vimentin, were concentrated near the tips of 
lamellipodial extensions of the repair cells, where they can func-
tion to regulate the cell’s migratory behavior. We also observed 
an increase in the soluble pool of vimentin in regions of active 
migration in response to injury. Accordingly, the dramatic effects 
on wound closure with both siRNA knockdown and WFA are likely 
to reflect the specific targeting of the vimentin soluble pool. We 
hypothesize that it is the soluble forms of vimentin filaments that 
play a critical role in regulating repair cell response to injury dur-
ing wound healing.
The finding that vimentin filaments had motile function sug-
gested that these filaments would be associated with motor pro-
teins, as is typical of other cytoskeletal elements involved in direct-
ing cell motility. We discovered that the motor protein myosin II, a 
principal regulator of actin filament–based cell movement, may 
also play a role in vimentin-based movement. Both myosin II iso-
forms, myosin IIA and IIB, localized to repair cells at the leading 
edge, but myosin IIB was predominant and was linked biochemi-
cally to vimentin in wounded lens cultures undergoing active 
repair. Myosin IIA and IIB have distinct roles in migration and dis-
tinct kinetic properties (Even-Ram and Yamada, 2007; Vicente-
Manzanares et al., 2009; Wang et al., 2011); myosin IIB has a higher 
affinity for ADP and duty ratio, which refers to its ability, under 
force-generating situations, to bind to actin longer than myosin IIA 
(Kovacs et al., 2003; Wang et al., 2003; Vicente-Manzanares et al., 
2009). These properties allow myosin IIB to exert tension for lon-
ger periods of time than myosin IIA (Kovacs et al., 2003; Wang 
et al., 2003; Vicente-Manzanares et al., 2009). Myosin II partici-
pates not only in the cellular response to mechanical stimuli, but 
also in the ability of a cell to sense pliability of its environment 
(Beningo et al., 2001, 2006; Chen, 2008; Vicente-Manzanares 
et al., 2009). The myosin IIB isoform is associated with acquisition 
of a mesenchymal phenotype and, in mammary cells treated with 
transforming growth factor-β to induce an EMT, its expression was 
required for their transmigration and invasion (Beach et al., 2011). 
These properties poise myosin II motor proteins with unique me-
chanical sensing and force-related properties and suggest that the 
myosin IIB isoform, in association with vimentin, has an important 
function in repair cells at the wound edge. To our knowledge, this 
is the first demonstration of a role for myosin II motor proteins with 
vimentin for cell migration in an injury model. This suggests the 
importance of furthering our understanding of the role of myosin II 
in regulation of vimentin function. In summary, the present study 
adds significant knowledge about how repair cells can perform 
unique functions in regulating the wound-healing process that re-
volves on vimentin function in cell migration.
MATERIALS AND METHODS
Ex vivo epithelial injury model preparation
To prepare ex vivo epithelial injury explants, lenses were removed 
from the eyes of embryonic day (E) 15 chicken embryo (Truslow 
Farms, Chestertown, MD, and B&E Eggs, York Springs, PA) by dis-
section (Walker et al., 2007, 2010). Then an incision was made in 
the anterior lens capsule—the thick basement membrane that sur-
rounds the lens—from which the lens fiber cell mass was removed 
by hydroelution (Walker et al., 2007, 2010). This procedure was 
modified from a human lens capsular bag model developed to 
study posterior capsular opacification (Liu et al., 1996). This pro-
cess, in which the lens epithelium remains tightly adherent to the 
repair cell morphology, properties that depend on microtubules. 
Our results suggest that vimentin-linked focal adhesions in the 
lamellipodia protrusions may provide unique properties to repair 
cells that are related to mechanical and motile functions required in 
their response to injury.
Vimentin-knockout mice exhibit defects in wound repair; how-
ever, complete loss of vimentin protein in these cells also results in 
dramatic effects on the organization of the actin cytoskeleton 
(Eckes et al., 1998), making it difficult to separate the role of these 
individual cytoskeletal systems in the wound-healing process. An 
siRNA knockdown approach allowed us to target the vimentin in-
termediate filament protein population just at the time of wound-
ing, allowing us to identify the immediate effects of loss of vimen-
tin function. In this study it is most likely that we are affecting the 
soluble, less stable pool of vimentin. The knockdown of vimentin 
impaired wound closure and the cells at the leading edge of the 
wound failed to extend lamellipodia. This finding revealed an es-
sential role for vimentin in repair cell function in wound closure. 
Altering vimentin function through the use of a vimentin inhibitor 
confirmed the siRNA-knockdown finding. For this study we used 
WFA, a plant-derived inhibitor that can bind to vimentin and block 
intermediate filament function (Bargagna-Mohan et al., 2007). 
Soluble vimentin is particularly sensitive to WFA (Bargagna-Mohan 
et al., 2013). In some cultured cell types, the effect of WFA on vi-
mentin filament organization has indirect effects on the organiza-
tion of actin microfilaments and microtubules (Bargagna-Mohan 
et al., 2007; Grin et al., 2012). However, we observed no similar 
effects of WFA on the repair cells in the wounded explant cultures, 
making the mock cataract surgery–wounded explants a good sys-
tem in which to use WFA to study the role of vimentin in wound 
repair. WFA altered vimentin organization in the repair cells in 
these explants without affecting the integrity of either actin fila-
ments or microtubules. Dramatic changes in repair cell shape and 
behavior were observed when the wounded cultures were ex-
posed to WFA, with repair cells failing to extend lamellipodial pro-
cesses. This effect interfered with repair cell function in wound 
healing and slowed wound closure. The WFA results paralleled 
those of vimentin siRNA knockdown in this mock cataract surgery 
model, showing that vimentin intermediate filaments are essential 
to repair cell function in regulating wound closure.
Intermediate filaments were classically viewed only as stable 
cytoskeletal structures whose principal function was to provide 
cells with mechanostability and resistance to mechanical stress 
(Lazarides, 1980; Kim and Coulombe, 2007), whereas it is now 
appreciated that vimentin intermediate filaments are dynamic 
structures (Prahlad et al., 1998; Helfand et al., 2004; Eriksson 
et al., 2009), with their state of assembly regulated by targeted 
phosphorylation events (Ivaska et al., 2007; Sihag et al., 2007). 
Differences in the assembly state of the vimentin filaments can 
affect vimentin function. It has been hypothesized that active free 
pools of vimentin (soluble vimentin) have functions distinct from 
those of large, rope-like vimentin filaments (Perlson et al., 2006; 
Kim and Coulombe, 2007; Lahat et al., 2010; Goldman et al., 
2012). These detergent-soluble populations are likely to be het-
erogeneous and contain short vimentin filaments that serve as 
building blocks for the larger, more mechanostable forms—the 
freer forms of vimentin likely including monomers, dimers, or te-
tramers. The soluble form of vimentin has been implicated as a 
long-distance messenger (Perlson et al., 2005). Data also show 
increased levels of soluble vimentin in disease states, as in sar-
coma tumor cell lines, a property correlated with increased sensi-
tivity to WFA (Lahat et al., 2010), highlighting a potential function 
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FIguRE 6: Disruption of vimentin function with WFA impaired extension of vimentin-rich lamellipodia by repair cells at 
the wound edge and slowed wound healing. (A) Immunostaining for vimentin (red) in wounded explants exposed to 
3.5 μM WFA demonstrates that this drug alters the intermediate filament networks of the repair cells and their cellular 
phenotype. The cells appear rounded, and their vimentin filaments are aggregated around the nucleus. (B) To determine 
the dose-dependent effect of WFA on repair cells, wounded lens explants were imaged at the wound edge by confocal 
microscopy after immunostaining for vimentin (red) and costaining for F-actin (green). Orthogonal cuts through Z-stacks 
were collected to examine the organization of the repair cells at the wound edge. The lowest concentration tested, 
1.5 μM WFA, had the least effect on repair cell morphology and their ability to extend lamellipodia along the basement 
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scanned, and densitometry analysis was performed (1D software; 
Eastman Kodak, Rochester, NY). For each protein analyzed, the 
densitometry results first were normalized to control, and then the 
ratio of each protein to glyceraldehyde-3-phosphate dehydroge-
nase (GAPDH) was calculated for each sample. All gels were run 
under reducing conditions. Antibodies used for Western blotting 
included vimentin (monoclonal antibody [mAb]; Developmental 
Studies Hybridoma Bank, Iowa City, IA), vimentin (polyclonal) 
antibody (a generous gift from Paul FitzGerald, University of 
California, Davis, CA), myosin IIB (mAb; Developmental Studies 
Hybridoma Bank), myosin IIA (polyclonal; Sigma-Aldrich), GAPDH 
(Santa Cruz Biotechnology, Santa Cruz, CA), and paxillin (mAb; 
BD Transduction Laboratories, Franklin Lakes, NJ).
Immunoprecipitation techniques
For immunoprecipitation studies, equal amounts of protein were 
used from ex vivo epithelial explants extracted in TX/OG from 
different days in culture or between treated and untreated 
samples. For immunoprecipitations, samples were incubated at 
4°C sequentially with primary antibody and TrueBlot Immunopre-
cipitation beads (eBioscience, San Diego, CA) and the immuno-
precipitates subjected to SDS/PAGE as described previously and 
earlier (Walker et al., 2002). Antibodies used included vimentin 
(Developmental Studies Hybridoma Bank) and paxillin (BD 
Transduction Laboratories). Immunoblots were scanned and 
densitometric analysis was performed using Kodak 1D software. 
To standardize these results for the paxillin IP, quantitative analysis 
was performed. For each protein analyzed, the densitometry re-
sults were normalized to D1 OAZ, and then the ratio of each co-
precipitated protein to the original immunoprecipitated protein 
was calculated for each sample. For vimentin IP, the ratio of myo-
sin IIA versus myosin IIB associated with vimentin was calculated 
for each sample.
siRNA knockdown of vimentin
Vimentin was silenced in ex vivo wounded lens explant cultures us-
ing a pool of four siRNA duplexes designed as a custom SMART-
pool plus by Dharmacon Research (Lafayette, CO). As a negative 
control, ex vivo explants were transfected with siControl (siC) non-
targeting siRNAs (Dharmacon). For maximum knockdown of vimen-
tin, wounded lens explant cultures were transfected at time of 
wounding and again at 24 h after injury using Lipofectamine 2000 
(Invitrogen) and 30–100 nM pool siRNA to vimentin or nontargeting 
siRNA control, according to manufacturer’s protocol.
capsule, mimics cataract surgery. The principal wound edge (lead-
ing edge) of the epithelium borders the area where the fiber cells 
had been attached (model, Figure 1). Cuts were made in the ante-
rior region of this tissue, creating additional wound edges that al-
lowed the explants to be flattened and pinned to the culture dish 
cell-side-up (Figure 1). The response of the lens epithelium to 
wounding within their native microenvironment was followed by 
microscopic imaging. Movement of the lens epithelial cells along 
the posterior aspects of the capsule was tracked using an SMZ800 
(Nikon, Tokyo, Japan) or AZ100 (Nikon) microscope and imaging 
software (NIS Elements; Nikon). The ex vivo epithelial explants 
were cultured in Media 199 (Invitrogen, Carlsbad, CA) containing 
1% penicillin/streptomycin (Mediatech-Cellgro, Manassas, VA) and 
1% l-glutamine (Mediatech-Cellgro) with 10% fetal calf serum (In-
vitrogen). Microtubules were depolymerized by growing injury ex-
plants in the presence of 3 μM nocodazole (Sigma-Aldrich, St. 
Louis, MO). To perturb vimentin function, ex vivo explants were 
grown in the presence of 1.5–3.5 μM withaferin A (Tocris, Ellisville, 
MO) or acrylamide (1–2 mM; Bio-Rad, Hercules, CA). Inhibitors 
were dissolved in dimethyl sulfoxide and added to the culture me-
dium. In all experiments, cultures were incubated in the presence 
or absence (vehicle controls) of inhibitor. Fresh inhibitor was added 
each day. Wound area was calculated over time using NIS Ele-
ments software. Measurements were exported and graphed in Ex-
cel (Microsoft, Redmond, WA).
Western blot analysis
Samples were extracted and lysed in TX/OG buffer (44.4 mM n-
octyl β-d glucopyranoside, 1% Triton X-100, 100 mM NaCl, 1 mM 
MgCl2, 5 mM EDTA, 10 mM imidazole) containing 1 mM sodium 
vanadate, 0.2 mM H2O2, and a protease inhibitor cocktail (Sigma-
Aldrich). For sequential extraction, samples were prepared as de-
scribed (Leonard et al., 2011). Briefly, studies using sequential 
extraction samples were extracted first in Triton (1% Triton X-100, 
100 mM NaCl, 1 mM MgCl2, 5 mM EDTA, 10 mM imidazole, 
pH 7.4), then in Triton/OG, and finally in 2× sample buffer 
(125 mM Tris-HCl, 4% SDS, 20% glycerol, 2% β-mercaptoethanol, 
0.5% bromophenol blue). Protein concentrations were deter-
mined with an assay (BCA Assay; Pierce, Rockford, IL). Proteins 
were separated on Tris-glycine gels (Novex, San Diego, CA), elec-
trophoretically transferred to membrane (Immobilon-P; Millipore, 
Billerica, MA), and immunoblotted as described previously (Walker 
and Menko, 1999). For detection, ECL reagent (Amersham Life 
Sciences, Arlington Heights, IL) was used. Immunoblots were 
membrane. WFA 2.5 μM induced rounding and piling up of the vimentin-rich repair cells at the wound edge, and the 
greatest effect on repair cell shape and phenotype at the wound edge is observed at 3.5 μM WFA. Repair cells in 
control wounded lens explants remain organized as a monolayer and extend their lamellipodia along the basement 
membrane in the direction of migration (dimethyl sulfoxide). (C, D) The effect of WFA on the organization of 
microfilament and microtubule cytoskeletal networks was examined by labeling the cells for F-actin using fluorescent 
phalloidin (green) or α-tubulin (red). Both F-actin and microtubules maintain a high level of organization in the presence 
of WFA in both repair cells and lens epithelial cells. The lack of effect of WFA on these other cytoskeletal elements is 
highlighted by the fact that actin remains organized in a cortical distribution in the lens epithelial cells (C, arrow). 
Changes in the distribution of these cytoskeletal elements within repair cells correspond to changes in cell shape caused 
by WFA treatment (C and D, arrowhead). (E) Wound closure for control wounded explants compared with wounded 
explants treated with 3.5 μM WFA, shown in phase contrast imaging. (F) WFA treatment affects wound closure in 
wounded explants in a dose-dependent manner. Although no effect on wound closure is observed at 1.5 μM WFA, 
which had little effect on repair cell morphology and ability to extend lamellipodia along the basement membrane (see 
B), wound closure was slowed with 2.5 μM WFA treatment, and the greatest inhibition was observed at 3.5 μM WFA, 
quantified for three independent experiments (F). Bar, 20 μm (A–D), 500 μm (phase images). Secondary antibody 
controls were performed, which demonstrated specificity of antibody staining (Supplemental Figure S1).
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Immunofluorescence
Epithelial explants were immunostained as 
described (Walker et al., 2007, 2010). Briefly, 
explants were fixed in 3.7% formaldehyde in 
phosphate-buffered saline (PBS) and perme-
abilized in 0.25% Triton X-100 (Sigma-Aldrich) 
in PBS before immunostaining. Cells were in-
cubated with primary antiserum followed by 
rhodamine-conjugated (Jackson ImmunoRe-
search Laboratories, West Grove, PA, and 
Millipore), fluorescein-conjugated (Jackson 
ImmunoResearch Laboratories), or Alexa 
Fluor 488–conjugated (Invitrogen-Molecular 
Probes, Carlsbad, CA) secondary antibodies. 
The following primary antibodies were used 
for the immunofluorescence studies: vimen-
tin (mAb; Developmental Studies Hybridoma 
Bank), vimentin (polyclonal) antibody (a gen-
erous gift from Paul FitzGerald), paxillin (mAb; 
BD Transduction Laboratories, Franklin Lakes, 
NJ), β4 integrin (polyclonal) antibody as de-
scribed in Sta Iglesia et al. (2000), α6 integrin 
(mAb; Covance, Princeton, NJ) myosin IIA 
(polyclonal, Sigma-Aldrich), myosin IIB (mAb; 
Developmental Studies Hybridoma Bank), α-
tubulin (mAb; Developmental Studies Hybri-
doma Bank), and α-tubulin (polyclonal) anti-
body (Cell Signaling, Danvers, MA). Some 
explants were counterstained with Alexa 
Fluor 488–conjugated phalloidin, which binds 
filamentous actin, and TO-PRO 3, a nuclear 
stain (Invitrogen-Molecular Probes). TUNEL 
assay was performed according to manufac-
turer’s protocol (Roche, Indianapolis, IN). Im-
munostained samples were examined with a 
confocal microscope (LSM 510; Zeiss, Thorn-
wood, NY). Either single images or Z-stacks 
were collected and analyzed; the data pre-
sented represent single optical planes, pro-
jected images, or orthogonal sections im-
aged from apical to basal direction.
FIguRE 7: Novel association between myosin II and vimentin during wound healing. To 
determine the distribution of myosin IIA and IIB in repair cells, wounded explants D1 postinjury 
were coimmunostained for myosin IIA (B, green) and myosin IIB (A, red; overlaid in C). Distinct 
patterns of distribution for these two isoforms were observed. Myosin IIA localized to stress 
fibers (arrows), whereas myosin IIB was predominately expressed throughout the cytoplasm of 
repair cells at the wound edge. Coimmunoprecipitation analysis at D1 postinjury revealed a 
previously unknown association between myosin II and vimentin (D). Lysates were 
immunoprecipitated (IP) for vimentin (vim) and immunoblotted for vimentin, myosin IIA (MyoIIA), 
or myosin IIB (MyoIIB), and the results are quantified (E) from three independent experiments. 
Whereas both myosin IIA and IIB were linked to vimentin, the greatest association occurred 
between myosin IIB and vimentin (E). Expression of myosin IIA, myosin IIB, and vimentin in WCLs 
is shown by direct immunoblotting (D). To examine the distribution of myosin IIB and vimentin in 
repair cells, D1 postinjury wounded lens explants were colabeled for myosin IIB (F, red), and 
vimentin (G green; overlaid in H). Myosin IIB was highly expressed in repair cells rich in vimentin 
located at the wound edge (H, white arrows). The boxed area is shown at higher magnification 
as an inset. Bars, 20 μm. A–H are shown as single optical sections. Secondary antibody controls 
were performed, which demonstrated specificity of antibody staining (Supplemental Figure S1).
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Supplemental Figure 1.  Controls for immunofluorescence staining.  Ex vivo explants were co- 
labeled with the following combinations of secondary antibodies:  rhodamine anti-mouse (A) and 
fluorescein anti-rabbit (B) or fluorescein anti-mouse (C) and rhodamine anti-rabbit (D). Results 
revealed that incubation with secondary antibodies did not result in non-specific staining. Mag. 
Bars = 20 m.   
 
Supplemental Figure 2.  Vimentin rich protrusions are enriched for the lamellipodia marker 
cortactin.    Ex vivo explants were co-immunolabeled for cortactin (A, red) and vimentin (B, 
green) and overlaid in (C).  Confocal imaging focused at the wound edge revealed that vimentin 
rich protrusions were enriched for cortactin at the tips of the lamellipodia.  Mag. Bar = 10m 
Secondary antibody controls were performed which demonstrated specificity of antibody 
staining (see Suppl. Fig. 1).  
 
Supplemental Figure 3.  Repair cells piled at the wound edge remained viable in the presence 
of WFA.  To determine if WFA affected the viability of repair cells piled at the wound edge 
which could impact wound closure, control and WFA treated ex vivo wounded explants were 
fixed 1D post-injury and analyzed by TUNEL assay (red) and immunostained for vimentin 
(green).  Little TUNEL staining (red, arrow) was noted in the repair cells at the wound edge in 
both control and WFA treated ex vivo explants. Mag. Bars = 20 m.   
 
 
Supplemental Figure 4.  Disruption of vimentin function with acrylamide interferes with wound 
closure.  In the presence of Acrylamide, a known vimentin disrupter, vimentin (green) 
organization was altered, and no longer formed an organized intermediate filament network as 
seen in cells at the wound edge in control treated explants (A).  Similar to WFA, treatment with 
Acrylamide slowed wound closure in a dose-dependent manner (B).  Wound closure for control 
wounded explants compared to wounded explants treated with 2mM Acrylamide shown in phase 
contrast images (C).  (A) Mag. Bar = 20m.  Phase images Mag. Bar = 500m.  Secondary 
antibody controls were performed which demonstrated specificity of antibody staining (see 
Suppl. Fig. 1).  
 




